What is the immediate nursing care plan for a 36-week pregnant patient with pre-eclampsia, controlled blood pressure (120/90 mmHg), on methyldopa and receiving Intravenous (IV) fluid (Peripheral Nutrition Support Solution (PNSS)) at 40 drops per minute (gtts/min)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nursing Care Plan for 36-Week Pregnant Patient with Controlled Pre-eclampsia

Immediate Nursing Priorities

Continue current management with methyldopa and IV fluids while implementing intensive maternal-fetal monitoring, as this patient has controlled blood pressure (120/90 mmHg) but remains at risk for rapid progression to severe pre-eclampsia or eclampsia at any time. 1, 2

Blood Pressure Monitoring and Management

  • Measure blood pressure every 1-2 hours using proper technique with appropriate cuff size, as errors in BP measurement have been implicated in maternal deaths 1
  • Maintain target BP below 160/110 mmHg to prevent hypertensive emergency and maternal stroke 1, 2
  • Current BP of 120/90 mmHg indicates adequate control with methyldopa, which is appropriate first-line therapy 1, 2, 3
  • Prepare for immediate intervention if systolic BP ≥160 mmHg or diastolic BP ≥110 mmHg, as this constitutes a hypertensive emergency requiring treatment within 15 minutes 2, 4

Neurological Assessment

  • Assess for symptoms of imminent eclampsia every 2-4 hours: severe headache, visual disturbances (blurred vision, scotomata, photophobia), altered mental status, and hyperreflexia 1, 5, 6
  • Monitor for seizure activity continuously, as 34% of eclamptic women have maximum diastolic BP ≤100 mmHg, meaning seizures can occur even with controlled BP 1
  • Keep magnesium sulfate readily available for seizure prophylaxis if severe features develop 2, 3

Renal and Hepatic Monitoring

  • Check urine protein at least daily using dipstick, as new or worsening proteinuria indicates disease progression 1, 5
  • Monitor for oliguria (urine output <30 mL/hour), which signals renal impairment and requires immediate physician notification 5, 3
  • Assess for epigastric or right upper quadrant pain every 4 hours, as this indicates hepatic involvement and potential HELLP syndrome 1, 5, 3

Fluid Management

  • Maintain IV PNSS at 40 gtts/min as ordered, but monitor closely for fluid overload, as pre-eclamptic patients are at high risk for pulmonary edema 1, 3
  • Strict intake and output monitoring with hourly urine output measurement 3
  • Assess for signs of pulmonary edema: dyspnea, tachypnea, crackles on auscultation, oxygen saturation <95% 5, 3
  • Limit total IV fluids to avoid volume overload, as endothelial dysfunction in pre-eclampsia causes capillary leak 5

Fetal Surveillance

  • Continuous fetal heart rate monitoring to detect fetal distress, as placental insufficiency is common in pre-eclampsia 1, 5
  • Ask patient about fetal movements every shift, as reduced movements indicate fetal compromise requiring immediate evaluation 1
  • Prepare for potential delivery, as severe pre-eclampsia at ≥34 weeks requires prompt delivery regardless of gestational age 1

Laboratory Monitoring

  • Daily complete blood count to monitor for thrombocytopenia (<100,000/μL), which is a severity criterion 5, 3
  • Daily liver function tests to detect elevated transaminases (>2x normal) indicating HELLP syndrome 5, 3
  • Daily renal function tests (creatinine, BUN) to assess for renal impairment 5, 3

Patient Education and Symptom Recognition

  • Educate patient to immediately report: severe headache, visual changes, epigastric pain, decreased fetal movement, or any new symptoms 1
  • Explain that pre-eclampsia can progress rapidly (average 2 weeks from diagnosis to life-threatening complications), even with controlled BP 1
  • Ensure patient understands the importance of bed rest and avoiding sudden position changes 3

Preparation for Potential Complications

  • Keep emergency equipment at bedside: oxygen, suction, airway management supplies, IV labetalol or hydralazine for hypertensive crisis 1, 4
  • Have magnesium sulfate protocol readily available with calcium gluconate antidote at bedside 2, 3
  • Coordinate with obstetric team for potential delivery planning, as this patient is at 36 weeks and may require delivery if severe features develop 1, 5

Critical Red Flags Requiring Immediate Physician Notification

  • BP ≥160/110 mmHg (hypertensive emergency) 1, 2, 4
  • New onset of severe headache or visual disturbances (imminent eclampsia) 1, 5
  • Epigastric or right upper quadrant pain (hepatic involvement/HELLP) 1, 5
  • Oliguria <30 mL/hour for 2 consecutive hours (renal failure) 5, 3
  • Decreased fetal movement or non-reassuring fetal heart rate (fetal compromise) 1, 5

Postpartum Considerations

  • Continue methyldopa postpartum initially, but avoid long-term use due to risk of postpartum depression 1
  • Monitor BP closely for 5-7 days postpartum, as BP typically rises during this period 1
  • Plan for BP assessment at 6 weeks postpartum to evaluate for persistent hypertension 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Pregnancy-Induced Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Severe pre-eclampsia and hypertensive crises.

Best practice & research. Clinical obstetrics & gynaecology, 2013

Research

Preeclampsia: an update.

Acta anaesthesiologica Belgica, 2014

Related Questions

What is the management approach for a pregnant woman with a history of preeclampsia and unstable hypertension?
What is the next management step for a preeclampsia patient with hypertension (high blood pressure) after Lower Segment Caesarean Section (LSCS)?
How can eclampsia cause toxic waste buildup in the kidneys and bleeding in the liver in a patient with pre-eclampsia?
Why is neurological assessment and monitoring of renal and hepatic function necessary for a pregnant woman with pre-eclampsia?
How should a pregnant woman with severe preeclampsia (high blood pressure and significant proteinuria) at 14 weeks gestation be managed?
What is the recommended follow-up blood work schedule for a patient with subclinical hypothyroidism, including Thyroid-Stimulating Hormone (TSH) and free Thyroxine (T4) (FT4) levels?
What is the best management plan for a patient with type 2 diabetes mellitus (T2DM), hyperlipidemia, gastroesophageal reflux disease (GERD), polyneuropathy, vitamin D deficiency, and left hip and knee pain, who has declining glycemic control with an A1c of 8.3%, and is currently taking Pioglitazone (Pioglitazone) 15 MG, Januvia (Sitagliptin) 100 MG, Rosuvastatin (Rosuvastatin) 20 MG, Ezetimibe (Ezetimibe) 10 MG, Omeprazole (Omeprazole) 20 MG, Gabapentin (Gabapentin) 300 MG, and Vitamin D (Ergocalciferol) 1.25 MG?
What is the treatment for Vogt-Koyanagi-Harada (VKH) disease?
What is the next step for a patient with no improvement in depressive symptoms after 9 months on 15 mg daily of escitalopram (Selective Serotonin Reuptake Inhibitor - SSRI)?
What is the recommended dosing and usage of Amlodipine (calcium channel blocker) in patients with hypertension or angina, considering factors such as age, renal function, and hepatic function?
Is it true that women and men who take methylfolate (a form of folate) 3 months prior to conception achieve pregnancy in a shorter time?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.